Combination Therapy Slows Osteosarcoma Growth and Extends Survival in Preclinical Models

Researchers at St. Jude Children's Research Hospital have discovered a potential therapeutic vulnerability in certain types of osteosarcoma. This finding comes from preclinical studies where a combination approach was shown to slow tumor growth and prolong survival.

Originally published by gnews